title: Orthotopic liver transplantation for alagille syndrome.
abstract: Alagille syndrome (AS) is a dominantly inherited, multisystem disorder involving the liver, heart, eyes, face, and skeleton. From October 1997 through July 2004, 260 pediatric orthotopic liver transplantations (OLTx) were performed in 231 patients. This report describes 21 patients of median age 1.95 years (range, 0.7-16.7) who had alagille syndrome. We present the technical features of the OLTx, incidence and type of complications, medical conditions related to the syndrome, need for retransplantation, as well as patient and graft survival rates. A split liver technique was used in 16 patients (76%) who received a left lateral segment (LLS) graft whereas 7 patients (33%) received a whole liver. Only cadaveric donors were used. The major surgical complications requiring reintervention in 11 patients (52%) included biliary problems (19%) and vascular complications (17%). One case of hepatic artery thrombosis required retransplantation. Three recipients (14%) died. All other patients are alive with an actuarial survival rate of 90% at 1 year and 80% at 5 years. The actuarial graft survival rate is 85% at 1 year and 75% at 5 years. Patients with AS, despite the associated cardiovascular anomalies, can be treated successfully by a combined approach between cardiologist, radiologist, cardiothoracic, and liver transplant surgeons. With careful planning and operative management, the results are comparable with those obtained with other more common cholestatic diseases.
authors.affiliation: Ospedali Riuniti di Bergamo, Bergamo, Italy. gmaldini@ospedaliriuniti.bergamo.it
authors.forename: G
authors.initials: G
authors.lastname: Maldini
authors.forename: E
authors.initials: E
authors.lastname: Torri
authors.forename: A
authors.initials: A
authors.lastname: Lucianetti
authors.forename: M
authors.initials: M
authors.lastname: Guizzetti
authors.forename: D
authors.initials: D
authors.lastname: Pinelli
authors.forename: A
authors.initials: A
authors.lastname: Bertani
authors.forename: V
authors.initials: V
authors.lastname: Corno
authors.forename: M
authors.initials: M
authors.lastname: Giovanelli
authors.forename: M
authors.initials: M
authors.lastname: Zambelli
authors.forename: P
authors.initials: P
authors.lastname: Stroppa
authors.forename: D
authors.initials: D
authors.lastname: Alberti
authors.forename: G
authors.initials: G
authors.lastname: Torre
authors.forename: M
authors.initials: M
authors.lastname: Spada
authors.forename: B
authors.initials: B
authors.lastname: Gridelli
authors.forename: M
authors.initials: M
authors.lastname: Colledan
mesh_terms: D000206:Actuarial Analysis; D016738:Alagille Syndrome / Q000601:surgery*; D006328:Cardiac Catheterization; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D016031:Liver Transplantation / Q000401:mortality / Q000706:statistics & numerical data*; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors